Bristol Myers earnings modestly beat Q3 estimates. The pharma giant also raised guidance. Bristol Myers stock edged higher Thursday.

The post Bristol Myers Earnings Top Q3 Estimates; Pharma Giant Raises Guidance appeared first on Investor’s Business Daily.